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ABSTRACT 
We describe an innovative framework for prescription of 
personalised health apps by integrating Personal Health Records 
(PHR) with disease-specific mobile applications for managing 
medical conditions and the communication with clinical 
professionals. The prescribed apps record multiple variables 
including medical history enriched with innovative features such 
as integration with medical monitoring devices and wellbeing 
trackers to provide patients and clinicians with a personalised 
support on disease management. Our framework is based on an 
existing PHR ecosystem called TreC, uniquely positioned 
between healthcare provider and the patients, which is being used 
by over 70.000 patients in Trentino region in Northern Italy. We 
also describe three important aspects of health app prescription 
and how medical information is automatically encoded through 
the TreC framework and is prescribed as a personalised app, ready 
to be installed in the patients’ smartphone. 
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INTRODUCTION 
Smartphones and their apps have permeated many aspects of our 
everyday life. There appears to be an app for almost anything, 
with varying degree of functionality. In this context, health is no 
exception. According to IMS Institute for Healthcare Informatics 
in 2015 there were over 165,000 health apps in Apple and Google 
app stores. This number represents double of the number of health 
apps recorded in 2013. This rise in health apps use can be 
attributed to interest in taking control of one’s health and having 
an increased autonomy in management of their disease. 
Complementary to this, there is a clear trend towards personalised 
treatment models, dubbed under the umbrella term “precision 
medicine” [1]. The premise of precision medicine is that 
successful disease treatment outcomes are dependent on 
incorporating individual phenotypes into treatment models. This 
realisation has given rise to personalised treatments, where 
genotype, as well as environmental and behavioural factors 
become an integral part of the course of treatment. Along this line, 
apps are being increasingly used to monitor multiple factors 
related to the wellbeing and course of treatment. Thus, integration 
of health apps in the care process will also require personalisation, 
in order to best support this process. 
However, the current personalisation model of health apps 
resembles that of traditional medicine where the majority of 
health apps are designed for the majority of consumers, while the 
degree of personalisation is rudimentary. This was especially 
evident in a global survey of 1,130 patients and caregivers carried 
out in the context of get-ehealth EU project [2] where for apps 
across 5 health categories, namely cancer, diabetes, pain, mental 
health, wellness, the importance of personalisation [3] emerged as 
a common challenge. Clearly, personalisation of apps is an 
important factor, and in our view personalisation should be guided 
by the existing diagnoses as well as medical advice. In this 
manner personalisation evolves towards prescription-based apps, 
akin to prescription of drugs, where medical aspects are the 
principal focus in this process. 
In this paper, we provide an overview of personalisation of 
medical apps, describe our view towards medical app prescription 
and describe our framework which enables medical app 
prescription. 
BEYOND APP PERSONALISATION 
Prescribing mobile apps by providers to help keep track of 
patients’ symptoms and provide real-time advice on treatment and 
medication can reduce costs and medical errors, and also improve 
the patient experience [4]. In our view, personalisation is an 
integral part of app prescription. However, app prescription goes 
beyond solely personalisation, since there are three important 
aspects to be considered. These aspects have come about as a 
result of our studies in using the platform to prescribe apps, 
primarily for patients with Type I diabetes.  
Discretion is the first aspect we describe. It should be in the 
discretion of the healthcare provider to customise particular 
aspects of the app in accordance to characteristics of the condition 
and the needs of the patient. This is because a system to support 
remote monitoring of chronically ill patients is not equally 
applicable to every patient. Each chronic condition requires 
monitoring of particular aspects and a targeted intervention. A 
classic example includes changes in glucose levels and 
recommended plan of action. Furthermore, the healthcare provider 
would modify app prescription according to patient 
characteristics, affecting compliance. For example an elderly 
patient might feel more comfortable and be more adherent to 
traditional methods of monitoring, such as maintaining a written 
log to track disease aspects. Placing app prescription at the 
discretion of healthcare provider gives them the means to 
prescribe the right app to the right patient and also customise 
these apps according to patient and disease characteristics. 
Personalisation is an indispensable aspect to app prescribing. 
Patients not only require individualised care and assistance but 
also have different psycho-social abilities. It is therefore necessary 
to create an app which takes the specific needs of each patient into 
consideration in order to activate the appropriate functionality.  
For example, an alarm for a child with type 1 diabetes would be 
activated in a different manner with respect to the alarm for a 
pregnant woman, where glucose targets are different as well as the 
ability to react to alarms. In the same manner, carbohydrate 
related functionality is more appropriate for the patients that have 
the ability to count carbohydrates. For other patients it might be 
sufficient to have a calendar that tracks glucose levels. 
Temporality is another essential aspect; remote monitoring or 
intervention through an app should be defined for a specific 
period of time, according to the condition of the patient, akin to a 
prescribed drug. For example, remote monitoring can be activated 
in the period after the initial diagnosis when patients need to be 
followed more closely. Continuous monitoring, as is the current 
practice, may provide data of less interest and increase processing 
and cognitive load. Provider access to data from the app can be 
discontinued, and later reactivated for a specific period of time as 
needed, for example in response to a change of therapy. 
During our pilot studies emerged the need to build a technology 
platform which can support apps offered to patients with chronic 
diseases, taking into account the requirements set out above. The 
app would be made available to the patient at the discretion of the 
healthcare provider, who would customise the app functionality 
according to patient’s needs. The app would be run for a defined 
period as deemed necessary. The three dimensions outlined above 
are similar to the process of prescribing a medication, thus app 
prescription could become part of the medical legislation. 
While the above discussion is based on our experience in 
designing and running a number of pilot trials, we also review the 
related work below. 
RELATED WORK 
A literature review [5] has shown that there is very little work 
carried out towards medical app prescription that fulfils the 
criteria outlined in Section 0. This is despite the fact that one of 
the best indicators of the importance of app prescription is the 
willingness of patients to accept them. This is illustrated from the 
survey of 2000 patients by Digitas Health, where it was found that 
over 90% of patients were willing to accept an offer of a mobile 
app from their provider rather than a written  paper prescription 
[6]. In this line, Mount Sinai hospital has created the RxUniverse1 
platform, which is curated list of existing apps on the App Stores 
that healthcare providers can use to prescribe to patients. BlueStar 
Diabetes app developed by WellDoc was approved by FDA for 
patients with type 2 diabetes. The app provides patients with 
personalised feedback and instructions regarding medications, 
lifestyle and self-management techniques. The BlueStar app helps 
patients keep track of blood glucose levels, medications, diet, and 
exercise while sharing their progress with their health care 
provider. In developing this app, Quinn et al. have carried out a 
study of 26 patients where control patients were asked to submit 
their blood glucose levels every 2 weeks to their providers. 
Intervention arm patients, on the other hand, received a Bluetooth-
enabled OneTouch ultra BG meter, with testing supplies, and a 
cell phone equipped with WellDoc, Inc, proprietary 
DiabetesManager software that had logs sent electronically to 
WellDoc provider at least every 4 weeks. Patients in the 
intervention group experienced a greater decrease in haemoglobin 
A1C values (2.03%) compared with the control group (0.68%) at 
3 months [7]. 
In a similar fashion, but on a different context (that of low 
socioeconomic strata - SES), Wayne et al. [8] conducted a pilot 
study (n=19) on a smartphone-assisted intervention intended to 
improve behavioural management of type 2 diabetes in an 
ethnically diverse, lower SES population within an urban 
community health setting. The health coach interventions were 
                                                                
1 http://www.rxuniverse.com/ 
personalised based on eating, physical activity patterns, and 
overall health goals. These interventions were created by a student 
trained in behaviour change techniques. For the 6-months study, 
the authors reported that the participants showed a mean reduction 
of 0.43% (SD 0.63) (P=.04) of HbA1c, demonstrating the 
potential clinical relevance of the intervention. 
A study by Mayo Clinic found 20 percent of the patients who 
attended cardiac rehab and used the app were readmitted to the 
hospital or visited the emergency department within 90 days, 
compared with 60 percent of those in the control group [9]. In this 
study, 44 patients at Mayo Clinic who were hospitalized following 
a heart attack and stent placement were divided into two groups: 
25 received cardiac rehab and the online/smartphone-based 
program; the 19 in the control group received only cardiac rehab.  
Another work on personalised intervention was carried out by Nes 
et al. [10]. The distinctive aspect of this work was that a therapist 
formulated personalised feedback, rather than automatically as it 
is the case with many other apps. The feedback was based on 
participants registering their eating behaviour, medication taking, 
physical activities and emotions three times daily using the mobile 
device. They also registered their fasting blood glucose level in 
the morning diary.   
However, as noted in [5] despite the thousands of health and 
fitness apps now available for download and the emerging interest 
in using them for improving health behaviours, very few have 
been tested in intervention settings. The types of published, peer-
reviewed app studies that were available for review were 
predominantly small sample pilot or feasibility. 
Considering that the majority of symptoms of mental disorders are 
reflected in the behaviour of patients, wearable and mobile 
sensing technologies can monitor mental disorders. In this respect, 
a number of apps have been used in the treatment of depression. 
For example, work by Burns et al. [11] developed the Mobilyze! 
App which was used in a pilot test (n=8), alongside a website and 
EMA for adults from the general population. The app used 
context-awareness to personalise ecological momentary 
interventions in order to support adherence to therapeutic 
activities. The authors reported a significant reduction in 
depression (Mini-International Neuropsychiatric Interview 
[MINI]: Z=2.15, beta [week]=-.65, P=.03), as well as depression 
and anxiety symptoms at posttest (Patient Health Questionnaire 
[PHQ-9]: d=1.95, P<.001; Quick Inventory of Depression 
Symptoms-Clinician Rated: d=2.28, P<.001; Generalized Anxiety 
Disorder-7 item scale: d=1.37, P<.001). 
A randomised controlled trial (RCT) was carried out by Reid et al. 
[12] and Kauer et al. [13] in using mobile phones in the early 
stages of adolescent depression (n=114). The intervention group 
received self-monitoring of mood, stress and daily activities, 
while control group received self-monitoring of daily activity only 
through the app developed on the mobile phone. The authors 
report no personalisation capability of their app and no significant 
differences were found at post-test and follow-up on outcomes of 
depression, anxiety, and stress among adolescents from general 
practice compared to control group. However, authors conclude 
that that self-monitoring increases emotional self-awareness, 
which in turn decreases depressive symptoms for young people 
with mild or more depressive symptoms.  
Watts et al. [14] carried out a RCT (n=35) comparing delivery of 
Cognitive Behaviour Therapy (CBT) through a mobile phone app, 
versus a traditional computer in patients with major depression. 
The authors report no personalisation of their CBT program, 
however based on their findings, the authors conclude that 
delivering a CBT program using a mobile application, can result 
in clinically significant improvements in outcomes for patients 
with depression. This is because both groups (computer and 
mobile app) were associated with statistically significant benefits 
at post-test and this result held also at 3 months follow up, where 
the depression reduction seen for both groups remained 
significant. 
APP-PRESCRIPTION PLATFORM 
Our work in creating a framework that allows prescription of 
apps, has begun with the TreC platform 
(https://trec.trentinosalute.net/). TreC, which stands for Cartella 
Clinica del Cittadino (Citizens’ Clinical Records) is a platform 
that enables citizens to access, manage and share information 
about their health and wellbeing.  
TreC is a platform that has been integrated into the health services 
provided by the Province of Trento. Thus, it is a mature platform 
that manages the health records of over 70,000 citizens. In 
addition, TreC is extensible in that it allows development and 
testing of new services connected to the platform. Thus far the 
platform has been used to support patients in two distinct areas of 
healthcare: i) oncology: development of a safe therapy system for 
the safe delivery of intravenous chemotherapy and a home 
monitoring system for monitoring and managing toxicity and 
improving adherence in patients receiving oral anticancer 
therapies at home [15] and ii) diabetes: a system consisting of a 
mobile diary and a web dashboard allowing patients to record 
disease-related information. This information can then be 
visualised by diabetologists through a dedicated dashboard while 
also allowing computation of insulin bolus and provide a rule-
based alarm functionality [16]. A number of other studies are also 
running in the platform (data not yet published). 
As can be seen from the above description, TreC is a mature and 
well tested platform that is in a unique position to support medical 
app prescription, since it manages the health records of the 
region’s citizens. TreC is characterised by an important 
conceptual feature, whereby, rather than developing a health 
information hub, TreC has been designed as a “system of 
systems” with an extensible architecture, where sub-systems can 
be developed to provide additional and specific functionality. 
Using TreC to prescribe apps entails a number of steps that are 
outlined in Figure 1, where the app is designed, through a drag 
and drop interface, to contain specific functionality and it is 
activated and installed in the patient’s device. This personalised 
app then is run over a defined period, where appropriate 
reminders are sent and data from remote monitoring is gathered. 
 
Figure 1 App-prescription process 
 
APP PRESCRIPTION SCENARIO 
As we noted in the introduction, in order for the apps to become 
prescription-based, we need to go beyond the current model of 
app personalisation, which takes into account only user-supplied 
data. To address this, our platform is being used by both 
healthcare providers and patients and has the capability to 
incorporate medical and lifestyle recommendations. In this respect 
we have envisioned a scenario, where by a citizen with a chronic 
disease, such as diabetes, is prescribed an app that will affect their 
behaviour change. 
Maria has been living with type 2 diabetes for the past number of 
years. She has been struggling with controlling her intake of 
simple carbohydrates. In order to address this issue, Maria has 
tried various apps available in the App stores related to diabetes 
management. However, she found that beyond simple messages of 
limiting carbohydrate intake and increasing physical activity, the 
apps did not provide the necessary functionality to manage her 
condition, nor did they take into account various aspects of her 
existing medical conditions. In addition to diabetes, Maria suffers 
from a congenital heart disease, which limits her ability to 
perform physical activity. Unfortunately, in the apps she 
downloaded there is no simple way to include all the information 
regarding her co-morbidities, as listed in her personal health 
record. 
Having been left unsatisfied with the offerings from app stores, 
Maria visits her primary care doctor and describes her struggle 
with controlling intake of simple carbohydrates and the limitations 
of the apps she has tried for the management of Type 2 diabetes. 
She also tells her doctor that sometimes she forgets to take her 
morning medications because she wakes up at different times 
throughout the week. 
Together with Maria, the doctor configures the TreC-Diabetes app 
that can access Maria’s health information from her PHR and can 
incorporate a series of personalised variables for better managing 
her disease such as Maria’s food intolerances, specific physical 
activity and nutrition targets and the desired frequency of glucose 
monitoring with her portable monitoring device. In addition, the 
doctor configures specific messages and reminders to be provided 
to Maria and sets the date for next visit, all from a single interface.  
Through the use of TreC-Diabetes app and TreC framework, the 
primary care doctor is able to encode all the information told by 
the patient, while also looking at her medical history for other 
conditions that the patient may have. This is done through an 
intuitive menu, where different triggers, conditions and limits can 
be specified. At the end of the consultation, Maria receives a 
notification on her smartphone, telling her that the prescribed 
TreC-Diabetes app is available and ready to be installed. Once 
Maria installs her pre-configured app she can use it  to log her 
food intake. Her blood glucose levels are automatically 
transmitted from her glucometer, which has been securely paired 
with the app. When the app detects that carbohydrate intake is 
getting near the recommended target, the app notifies Maria to 
limit further intake of carbohydrates and also recommends 
physical exercise. The app monitors in the background the amount 
of physical activity she has performed, using data from her fitness 
tracking device. Once the safe limits of physical activity have 
been achieved, as encoded by her primary physician based on her 
congenital heart disease, the app sends a notification to Maria, 
recommending her to gradually reduce her exercise intensity. All 
the data gathered from the app is periodically sent to the TreC 
platform, where it becomes part of her personal health records, 
accessible to her primary-care provider. The next morning the app 
reminds Maria to take her diabetes medication and she begins the 
day with a feeling of being in control of her condition chronic 
conditions, with reduced subjective burden of disease. 
CONCLUSION 
Smartphones apps have great potential to play an important role in 
implementation of precision medicine, specifically personalised 
treatments that consider specific patient aspects. However, as 
things currently stand, the personalisation of apps is very 
rudimentary, where only simplistic information is being 
considered, such as physical characteristics of the patient. Co-
existing medical conditions or medical history is typically not 
taken into consideration. 
In order to address these issues we have described our app-
prescription platform based on TreC which allows creation and 
integration of apps on prescription basis. TreC can achieve this 
because it is uniquely positioned between the healthcare providers 
and patients. Therefore, it can make use of medical information, 
such as existing conditions or risk factors in order to design and 
build apps that take these aspects into consideration. This 
functionality of prescription-based apps using TreC is already 
being tested in a pilot study. 
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